Concepedia
Statistics
Publications
8
Citations
1K
H-Index
Active since
2006
Affiliations
Genmab (Netherlands)(Current)
Genmab (United States)
Christian-Albrechts-Universität zu Kiel
University of Southern Denmark
Biocon (Switzerland)
Bart E.C.G. de Goeij is an author at Genmab (Netherlands) specializing in pharmacy, antibody-drug conjugates, and molecular oncology.
Publications per year
2006–2023
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
Aran F. Labrijn, Joyce Meesters, Bart E.C.G. de Goeij et al. · Proceedings of the National Academy of Sciences · 2013 · 330 citations · Full text
Pharmacy, Biotechnology, Molecular Biology +17
An Antibody–Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors
Esther C.W. Breij, Bart E.C.G. de Goeij, Sandra Verploegen et al. · Cancer Research · 2013 · 221 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity
Laura A. Smit, Delfine Y.H. Hallaert, René Spijker et al. · Blood · 2006 · 160 citations
Life Sciences, Cell Biology, Oncology +8
Efficient Payload Delivery by a Bispecific Antibody–Drug Conjugate Targeting HER2 and CD63
Bart E.C.G. de Goeij, Tom Vink, Hendrik ten Napel et al. · Molecular Cancer Therapeutics · 2016 · 131 citations · Full text
Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17
High Turnover of Tissue Factor Enables Efficient Intracellular Delivery of Antibody–Drug Conjugates
Bart E.C.G. de Goeij, David Satijn, Claudia Freitag et al. · Molecular Cancer Therapeutics · 2015 · 94 citations
Pharmacy, Oncology, Pharmacology +16
1–5 of 8